Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis (clinical trials).

R Laham1

  • 1Angiogenesis Research Center and BIDMC/Harvard Medical School, Boston, MA 02215, USA. rlaham@bidmc.havard.edu

The Canadian Journal of Cardiology
|May 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2001
Same author

Therapeutic angiogenesis in cardiology using protein formulations.

Cardiovascular research·2001
Same author

Managing the embolization problem during saphenous vein graft intervention.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·1999
Same author

Evaluation of outpatient initiation of antiarrhythmic drug therapy in patients reverting to sinus rhythm after an episode of atrial fibrillation.

The American journal of cardiology·1999
Same author

Angiographic methods to assess human coronary angiogenesis.

American heart journal·1999
Same journal

Neighborhood-Level Material Resources and Risk of Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease.

The Canadian journal of cardiology·2026
Same journal

Storm Clouds Coming: Red-Flag Warning for Hypertension Prevalence and Control in the Post-COVID-19 Era.

The Canadian journal of cardiology·2026
Same journal

Universal coverage, unequal care: Why Canada needs a national cardiovascular access ledger.

The Canadian journal of cardiology·2026
Same journal

Prolonged Loop Recorder Retention: Safety, Diagnostic Yield, and the Case for Community-Based Explantation.

The Canadian journal of cardiology·2026
Same journal

Multimodality Fusion Imaging of Subclinical Systemic Right Ventricular Remodeling in Congenitally Corrected Transposition of the Great Arteries.

The Canadian journal of cardiology·2026
Same journal

Percutaneous Coronary Intervention Prior to Transcatheter Aortic Valve Implantation: A Bayesian Meta-Analysis of Randomized Controlled Trials.

The Canadian journal of cardiology·2026
See all related articles

Therapeutic angiogenesis shows promise for treating vascular disease in patients ineligible for surgery. Growth factors like FGF and VEGF can stimulate new blood vessel growth, offering new treatment strategies.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Biotechnology

Background:

  • Vascular disease impacts patients lacking surgical options.
  • Therapeutic angiogenesis presents a potential alternative treatment.
  • Early clinical trials began in 1998.

Purpose of the Study:

  • To review clinical trial results for therapeutic angiogenesis.
  • To assess the efficacy of growth factors in inducing angiogenesis.
  • To highlight advancements in delivery methods for angiogenesis therapies.

Main Methods:

  • Review of published clinical trial data on therapeutic angiogenesis.
  • Analysis of studies using basic fibroblast growth factor (FGF) and human vascular endothelial growth factor (VEGF).
  • Evaluation of evolving delivery modalities and strategies.

Related Experiment Videos

Main Results:

  • Growth factors like FGF and VEGF demonstrate the ability to induce functionally significant angiogenesis.
  • Several clinical trials have been completed or are ongoing, with results under review.
  • Advancements in delivery systems are enhancing therapeutic potential.

Conclusions:

  • Therapeutic angiogenesis is a viable option for specific vascular disease patients.
  • Growth factor-induced angiogenesis is effective in promoting new blood vessel formation.
  • Ongoing research and evolving delivery strategies continue to advance this field.